Christopher

In a report published Tuesday, Credit Suisse analyst Christopher Parkinson initiated coverage of Arcadia Biosciences Inc (NASDAQ: RKDA) with an Outperform rating and $14 price target, as the company is a "best-in-class" agricultural technology company that is poised to benefit from the secular need...

Christopher Mutascio of Keefe, Bruyette & Woods downgraded shares of U.S. Bancorp (NYSE: USB) on Monday to Underperform from Market Perform with a newly established $44 price target. “We still view the company as a high-quality franchise led by a strong management team,” Mutascio wrote in a...